Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.

ClinicalTrials.gov ID: NCT02032888

Public ClinicalTrials.gov record NCT02032888. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 1:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)

Study identification

NCT ID
NCT02032888
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
238 participants

Conditions and interventions

Conditions

Interventions

  • Daclatasvir Drug
  • Sofosbuvir Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2014
Primary completion
Sep 30, 2014
Completion
Dec 31, 2014
Last update posted
Oct 26, 2015

2014 – 2015

United States locations

U.S. sites
37
U.S. states
21
U.S. cities
30
Facility City State ZIP Site status
University Of Alabama At Birmingham Birmingham Alabama 35294
Pacific Oaks Medical Group Beverly Hills California 90211
Va Long Beach Healthcare System Long Beach California 90822
Peter J Ruane Md Inc Los Angeles California 90036
Anthony M. Mills Md Inc Los Angeles California 90069
Jeffrey Goodman Special Care Clinic Los Angeles California 90232
Ucsd Antiviral Research Center (Avrc) San Diego California 92103
Precision Research Institute, Llc San Diego California 92114
University Of California San Francisco San Francisco California 94110
University Of Colorado Aurora Colorado 80045
Whitman Walker Health Washington D.C. District of Columbia 20009
Medstar Washington Hospital Center Washington D.C. District of Columbia 20010
Capital Medical Associates Washington D.C. District of Columbia 20036
Midway Immunology And Research Center Ft. Pierce Florida 34982
University Of Miami Schiff Center For Liver Diseases Miami Florida 33136
Orlando Immunology Center Orlando Florida 32803
Infect. Disease Specialists Decatur Georgia 30033
Indiana University Health - University Hospital Indianapolis Indiana 46202
Digestive Disease Associates, P.A. Baltimore Maryland 21229
Johns Hopkins University Lutherville Maryland 21093
Henry Ford Health System Detroit Michigan 48202
Washington University School Of Medicine St Louis Missouri 63110
Southwest Care Center Sante Fe New Mexico 87505
Binghamton Gastroenterology Associates Binghamton New York 13903
Icahn School Of Medicine At Mount Sinai New York New York 10029
University Of Cincinnati Cincinnati Ohio 45267
Healthcare Research Consultants Tulsa Oklahoma 74135
Oregon Health Science Univ Portland Oregon 97239
Lehigh Valley Health Network Allentown Pennsylvania 18102
University Gastroenterology Providence Rhode Island 02905
The Miriam Hospital Providence Rhode Island 02906
Tarrant County Inf Dis Assoc Fort Worth Texas 76104
Cure C Consortium Houston Texas 77004
University Of Texas Health Science Center At Houston Houston Texas 77030
Clinical Research Centers Of America Murray Utah 84123
Mcguire D V A M C Richmond Virginia 23249
Harborview Medical Center Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02032888, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 26, 2015 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02032888 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →